[SCHEDULE 13G/A] Anteris Technologies Global Corp. SEC Filing
Anteris Technologies Global Corp. received a Schedule 13G/A disclosing that Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. and Joseph Edelman collectively beneficially own 1,705,130 shares of the issuer's common stock, representing 4.7% of the outstanding class based on 36,062,370 shares outstanding. The Master Fund directly holds the shares; Perceptive Advisors is the fund's investment manager and Mr. Edelman is the managing member, and each may be deemed to beneficially own the shares. No sole voting or dispositive power is reported; all voting and dispositive power is shared.
Anteris Technologies Global Corp. ha ricevuto un Schedule 13G/A che indica che Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. e Joseph Edelman detengono congiuntamente la proprietà beneficiaria di 1.705.130 azioni del capitale sociale dell'emittente, pari al 4,7% della classe in circolazione su un totale di 36.062.370 azioni in circolazione. Le azioni sono detenute direttamente dal Master Fund; Perceptive Advisors è il gestore degli investimenti del fondo e il sig. Edelman è il membro amministratore, perciò ciascuno può essere considerato beneficiario delle azioni. Non è riportato alcun potere di voto o dispositive esclusivo; tutti i poteri di voto e dispositivi sono esercitati congiuntamente.
Anteris Technologies Global Corp. recibió un Schedule 13G/A que revela que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. y Joseph Edelman poseen colectivamente la propiedad beneficiaria de 1.705.130 acciones ordinarias de la emisora, lo que representa el 4,7% de la clase en circulación sobre 36.062.370 acciones en circulación. El Master Fund posee directamente las acciones; Perceptive Advisors es el gestor de inversiones del fondo y el Sr. Edelman es el miembro administrador, por lo que cada uno puede considerarse beneficiario de las acciones. No se informa de poder exclusivo de voto o disposición; todos los poderes de voto y disposición son compartidos.
Anteris Technologies Global Corp.는 Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. 및 Joseph Edelman이 함께 발행회사의 보통주 1,705,130주를 실질적으로 보유하고 있음을 공개한 Schedule 13G/A를 접수했으며, 이는 총 36,062,370주 중 유통주식의 4.7%에 해당합니다. 해당 주식은 Master Fund가 직접 보유하고 있으며 Perceptive Advisors는 그 펀드의 투자매니저, Edelman 씨는 운영 멤버로서 각자 주식을 실질적으로 보유한 것으로 간주될 수 있습니다. 단독 의결권 또는 처분권은 보고되지 않았으며, 모든 의결권 및 처분권은 공동으로 보유됩니다.
Anteris Technologies Global Corp. a reçu un Schedule 13G/A révélant que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. et Joseph Edelman détiennent conjointement la propriété bénéficiaire de 1 705 130 actions ordinaires de l'émetteur, représentant 4,7 % de la catégorie en circulation sur un total de 36 062 370 actions en circulation. Le Master Fund détient directement les actions ; Perceptive Advisors est le gestionnaire d'investissement du fonds et M. Edelman est le membre gestionnaire, de sorte que chacun peut être considéré comme bénéficiaire des actions. Aucun pouvoir exclusif de vote ou de disposition n'est déclaré ; tous les pouvoirs de vote et de disposition sont partagés.
Anteris Technologies Global Corp. erhielt ein Schedule 13G/A, das offenlegt, dass Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. und Joseph Edelman gemeinsam 1.705.130 Aktien der Stammaktien des Emittenten wirtschaftlich besitzen, was 4,7% der ausstehenden Klasse bei insgesamt 36.062.370 ausstehenden Aktien entspricht. Die Aktien werden direkt vom Master Fund gehalten; Perceptive Advisors ist der Investmentmanager des Fonds und Herr Edelman ist das geschäftsführende Mitglied, sodass jeder von ihnen als wirtschaftlicher Eigentümer der Aktien angesehen werden kann. Alleinige Stimm- oder Verfügungsgewalt wird nicht angegeben; Stimm- und Verfügungsrechte werden gemeinschaftlich ausgeübt.
- Clear disclosure of beneficial ownership totaling 1,705,130 shares
- Ownership percentage provided (4.7% of 36,062,370 shares outstanding)
- Signatures and certifications included from the reporting persons
- None.
Insights
TL;DR: A 4.7% passive stake disclosed by an investment manager and affiliated fund; below the 5% reportable threshold for control but material for ownership monitoring.
The filing shows the Master Fund directly holds 1,705,130 shares (4.7%) with no sole voting or dispositive power reported and all voting/dispositive power listed as shared. Perceptive Advisors, as manager, and Joseph Edelman, as managing member, are identified as persons who may be deemed to beneficially own these shares. The statement is presented on Schedule 13G/A, indicating a passive investor reporting under the applicable rule set rather than an activist 13D filing. This is a straightforward disclosure of ownership useful for cap table tracking and shareholder concentration analysis.
TL;DR: Disclosure clarifies beneficial ownership and voting arrangements but indicates no controlling stake or sole authority.
The report attributes shared voting and dispositive power to the reporting entities while showing zero sole power, which suggests decisions over these shares are not unilaterally controlled by the filer. The filing includes the issuer address and references the outstanding share count used to calculate the 4.7% figure. It contains standard certifications and signatures from Joseph Edelman for all reporting persons, consistent with regulatory requirements.
Anteris Technologies Global Corp. ha ricevuto un Schedule 13G/A che indica che Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. e Joseph Edelman detengono congiuntamente la proprietà beneficiaria di 1.705.130 azioni del capitale sociale dell'emittente, pari al 4,7% della classe in circolazione su un totale di 36.062.370 azioni in circolazione. Le azioni sono detenute direttamente dal Master Fund; Perceptive Advisors è il gestore degli investimenti del fondo e il sig. Edelman è il membro amministratore, perciò ciascuno può essere considerato beneficiario delle azioni. Non è riportato alcun potere di voto o dispositive esclusivo; tutti i poteri di voto e dispositivi sono esercitati congiuntamente.
Anteris Technologies Global Corp. recibió un Schedule 13G/A que revela que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. y Joseph Edelman poseen colectivamente la propiedad beneficiaria de 1.705.130 acciones ordinarias de la emisora, lo que representa el 4,7% de la clase en circulación sobre 36.062.370 acciones en circulación. El Master Fund posee directamente las acciones; Perceptive Advisors es el gestor de inversiones del fondo y el Sr. Edelman es el miembro administrador, por lo que cada uno puede considerarse beneficiario de las acciones. No se informa de poder exclusivo de voto o disposición; todos los poderes de voto y disposición son compartidos.
Anteris Technologies Global Corp.는 Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. 및 Joseph Edelman이 함께 발행회사의 보통주 1,705,130주를 실질적으로 보유하고 있음을 공개한 Schedule 13G/A를 접수했으며, 이는 총 36,062,370주 중 유통주식의 4.7%에 해당합니다. 해당 주식은 Master Fund가 직접 보유하고 있으며 Perceptive Advisors는 그 펀드의 투자매니저, Edelman 씨는 운영 멤버로서 각자 주식을 실질적으로 보유한 것으로 간주될 수 있습니다. 단독 의결권 또는 처분권은 보고되지 않았으며, 모든 의결권 및 처분권은 공동으로 보유됩니다.
Anteris Technologies Global Corp. a reçu un Schedule 13G/A révélant que Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. et Joseph Edelman détiennent conjointement la propriété bénéficiaire de 1 705 130 actions ordinaires de l'émetteur, représentant 4,7 % de la catégorie en circulation sur un total de 36 062 370 actions en circulation. Le Master Fund détient directement les actions ; Perceptive Advisors est le gestionnaire d'investissement du fonds et M. Edelman est le membre gestionnaire, de sorte que chacun peut être considéré comme bénéficiaire des actions. Aucun pouvoir exclusif de vote ou de disposition n'est déclaré ; tous les pouvoirs de vote et de disposition sont partagés.
Anteris Technologies Global Corp. erhielt ein Schedule 13G/A, das offenlegt, dass Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. und Joseph Edelman gemeinsam 1.705.130 Aktien der Stammaktien des Emittenten wirtschaftlich besitzen, was 4,7% der ausstehenden Klasse bei insgesamt 36.062.370 ausstehenden Aktien entspricht. Die Aktien werden direkt vom Master Fund gehalten; Perceptive Advisors ist der Investmentmanager des Fonds und Herr Edelman ist das geschäftsführende Mitglied, sodass jeder von ihnen als wirtschaftlicher Eigentümer der Aktien angesehen werden kann. Alleinige Stimm- oder Verfügungsgewalt wird nicht angegeben; Stimm- und Verfügungsrechte werden gemeinschaftlich ausgeübt.